Benitec Biopharma is a biotechnology company developing a therapeutic platform that combines RNA interference with gene therapy. It aims to provide the silencing of disease-causing genes. The company offers ddRNAi, a technology that allows the development of product candidates in chronic and life-threatening human disease areas, including oculopharyngeal muscular dystrophy and hepatitis B virus.